Cells into clinical trials. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Cell Line, Tumor

Diseases30

Neoplasms Breast Neoplasms Recurrence Disease Progression Stroke HIV Infections Lung Neoplasms Acute Disease Pain Chronic Disease Drug-Related Side Effects and Adverse Reactions Cardiovascular Diseases Myocardial Infarction Prostatic Neoplasms Neoplasm Recurrence, Local Diabetes Mellitus, Type 2 Postoperative Complications Neoplasm Metastasis Disease Models, Animal Colorectal Neoplasms Melanoma Heart Failure Nausea Weight Loss Arthritis, Rheumatoid Carcinoma, Non-Small-Cell Lung Fatigue Hemorrhage Brain Neoplasms Hypertension

Chemicals and Drugs42

Placebos Antineoplastic Agents Drugs, Investigational Drug Combinations Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Biological Markers Cancer Vaccines Anti-HIV Agents Anti-Bacterial Agents Paclitaxel Fluorouracil Antihypertensive Agents Anticoagulants Cardiovascular Agents Cyclophosphamide Hydroxymethylglutaryl-CoA Reductase Inhibitors Angiogenesis Inhibitors Cisplatin Platelet Aggregation Inhibitors Doxorubicin Anti-Inflammatory Agents Hypoglycemic Agents Methotrexate Deoxycytidine Immunologic Factors Anti-Infective Agents, Local Recombinant Proteins Fibrinolytic Agents Immunosuppressive Agents Pyrroles Protein Kinase Inhibitors Antidepressive Agents Aspirin Tumor Markers, Biological Piperazines Quinolines Antiviral Agents Sirolimus Plant Extracts Vitamins Pyrimidines

Analytical, Diagnostic and Therapeutic Techniques and Equipment106

Clinical Trials as Topic Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Clinical Trials, Phase I as Topic Treatment Outcome Research Design Controlled Clinical Trials as Topic Double-Blind Method Randomized Controlled Trials as Topic Patient Selection Multicenter Studies as Topic Placebos Clinical Trials, Phase IV as Topic Clinical Protocols Prospective Studies Follow-Up Studies Single-Blind Method Early Termination of Clinical Trials Drug Therapy, Combination Drug Administration Schedule Sample Size Pilot Projects Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Severity of Illness Index Endpoint Determination Administration, Oral Survival Analysis Questionnaires Risk Factors Reproducibility of Results Prognosis Data Interpretation, Statistical Pain Measurement Drug Evaluation Feasibility Studies Disease-Free Survival Cross-Over Studies Survival Rate Risk Assessment Exercise Therapy Therapeutic Human Experimentation Drug Approval Random Allocation Meta-Analysis as Topic Infusions, Intravenous Phytotherapy Analysis of Variance Retrospective Studies Chemotherapy, Adjuvant Kaplan-Meier Estimate Treatment Failure Drug Evaluation, Preclinical Predictive Value of Tests Immunotherapy Molecular Targeted Therapy Neoplasm Staging Cohort Studies Statistics, Nonparametric Genetic Therapy Proportional Hazards Models Sensitivity and Specificity Incidence Control Groups Human Experimentation Multivariate Analysis Models, Statistical Chi-Square Distribution Administration, Topical Regression Analysis Remission Induction Statistics as Topic Quality-Adjusted Life Years Disease Models, Animal Drug Delivery Systems Pain Management Disability Evaluation Physical Therapy Modalities Therapies, Investigational Magnetic Resonance Imaging Injections, Intramuscular Chemoprevention Data Collection Pragmatic Clinical Trials as Topic Drug Discovery Individualized Medicine Risk Drug Design Drug Therapy Probability Program Evaluation Injections, Intravenous Therapy, Computer-Assisted Odds Ratio Longitudinal Studies Logistic Models Linear Models Drug Monitoring Medicine, Chinese Traditional Self Care Musculoskeletal Manipulations Cluster Analysis Confidence Intervals Maximum Tolerated Dose Activities of Daily Living Product Surveillance, Postmarketing

Psychiatry and Psychology11

Patient Compliance Cognitive Therapy Pain Counseling Behavior Therapy Motivation Smoking Cessation Decision Making Risk Reduction Behavior Psychiatric Status Rating Scales Health Knowledge, Attitudes, Practice

Phenomena and Processes16

Time Factors Dose-Response Relationship, Drug Pain Pregnancy Sensitivity and Specificity Recovery of Function Chi-Square Distribution Exercise Risk Weight Loss Probability Algorithms Odds Ratio Drug Resistance, Neoplasm Trial of Labor Maximum Tolerated Dose

Disciplines and Occupations14

Research Design Outcome Assessment (Health Care)Evidence-Based Medicine Biomedical Research Medical Oncology Therapeutic Human Experimentation Translational Medical Research Human Experimentation Statistics as Topic Comparative Effectiveness Research Drug Discovery Individualized Medicine Drug Design Research Report

Anthropology, Education, Sociology and Social Phenomena12

Quality of Life Informed Consent Drug Approval United States Food and Drug Administration Patient Education as Topic National Cancer Institute (U.S.)National Institutes of Health (U.S.)National Institute on Drug Abuse (U.S.)Exercise International Cooperation Medicine, Chinese Traditional Activities of Daily Living

Technology, Industry, Agriculture4

Dietary Supplements Drug Industry Quality Control Vitamins

Humanities7

Quality of Life Ethics Committees, Research Therapeutic Equipoise Conflict of Interest Ethics, Research Ethical Review Ethics, Medical

Information Science15

Questionnaires Data Interpretation, Statistical Survival Rate Publishing Publication Bias Incidence Internet Quality-Adjusted Life Years Periodicals as Topic Data Collection Therapy, Computer-Assisted Algorithms Research Report Review Literature as Topic Databases, Factual

Named Groups4

Research Subjects Patient Dropouts Research Personnel Infant, Newborn

Health Care94

Clinical Trials as Topic Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Clinical Trials, Phase I as Topic Treatment Outcome Controlled Clinical Trials as Topic Double-Blind Method Randomized Controlled Trials as Topic Patient Selection Multicenter Studies as Topic Clinical Trials Data Monitoring Committees Clinical Trials, Phase IV as Topic Clinical Protocols Prospective Studies Follow-Up Studies Single-Blind Method Early Termination of Clinical Trials Sample Size Pilot Projects Outcome Assessment (Health Care)Severity of Illness Index Cost-Benefit Analysis Survival Analysis Patient Compliance Informed Consent Placebo Effect Questionnaires Risk Factors Reproducibility of Results Data Interpretation, Statistical Patient Participation Feasibility Studies Disease-Free Survival Cross-Over Studies Survival Rate Risk Assessment Intention to Treat Analysis Random Allocation United States Food and Drug Administration Meta-Analysis as Topic Patient Education as Topic Patient Satisfaction Research Support as Topic Bias (Epidemiology)Analysis of Variance Retrospective Studies National Cancer Institute (U.S.)Guidelines as Topic Kaplan-Meier Estimate Treatment Failure Practice Guidelines as Topic National Institutes of Health (U.S.)Predictive Value of Tests Ethics Committees, Research Cohort Studies Statistics, Nonparametric Age Factors Safety National Institute on Drug Abuse (U.S.)Proportional Hazards Models Sensitivity and Specificity Incidence Counseling Multivariate Analysis Models, Statistical Chi-Square Distribution Regression Analysis Statistics as Topic Quality-Adjusted Life Years Health Care Costs Cancer Care Facilities Comparative Effectiveness Research Selection Bias Pain Management Conflict of Interest Data Collection Pragmatic Clinical Trials as Topic Risk Ethics, Research Ethical Review Societies, Medical Probability Program Evaluation Health Knowledge, Attitudes, Practice Odds Ratio Longitudinal Studies Logistic Models Linear Models Ethics, Medical Eligibility Determination Self Care Cluster Analysis Confidence Intervals Activities of Daily Living

Geographicals5

United States Great Britain Europe Canada Australia

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Clinical Trials as Topic Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Clinical Trials, Phase I as Topic Treatment Outcome Research Design Controlled Clinical Trials as Topic Double-Blind Method Randomized Controlled Trials as Topic Patient Selection Multicenter Studies as Topic Placebos Clinical Trials Data Monitoring Committees Time Factors Clinical Trials, Phase IV as Topic Clinical Protocols Neoplasms Prospective Studies Follow-Up Studies Single-Blind Method Early Termination of Clinical Trials Antineoplastic Agents Drug Therapy, Combination Drug Administration Schedule Sample Size Quality of Life Pilot Projects Research Subjects United States Outcome Assessment (Health Care)Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Severity of Illness Index Endpoint Determination Cost-Benefit Analysis Evidence-Based Medicine Dose-Response Relationship, Drug Administration, Oral Survival Analysis Patient Compliance Drugs, Investigational Informed Consent Placebo Effect Questionnaires Risk Factors Biomedical Research Reproducibility of Results Breast Neoplasms Recurrence Prognosis Disease Progression Medical Oncology Data Interpretation, Statistical Dietary Supplements Patient Participation Pain Measurement Drug Evaluation Feasibility Studies Disease-Free Survival Cross-Over Studies Survival Rate Risk Assessment Exercise Therapy Stroke Therapeutic Human Experimentation Drug Approval Intention to Treat Analysis Random Allocation United States Food and Drug Administration Meta-Analysis as Topic HIV Infections Drug Industry Drug Combinations Cognitive Therapy Antibodies, Monoclonal Infusions, Intravenous Patient Education as Topic Patient Dropouts Antibodies, Monoclonal, Humanized Biological Markers Phytotherapy Patient Satisfaction Lung Neoplasms Research Support as Topic Bias (Epidemiology)Analysis of Variance Retrospective Studies National Cancer Institute (U.S.)Chemotherapy, Adjuvant Guidelines as Topic Kaplan-Meier Estimate Treatment Failure Publishing Practice Guidelines as Topic National Institutes of Health (U.S.)Acute Disease Pain Drug Evaluation, Preclinical Predictive Value of Tests Chronic Disease

No FAQ available that match "cells into clinical trials"